| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.49 | 0.029 | 0.521 | 5 Hydroxytryptamine release stimulant | 0.521 0.024 CID_129154 | CID_129154 | |
| 0.472 | 0.025 | 0.472 | Caspase 3 stimulant | 0.464 0.026 CID_129154 | ||
| 0.48 | 0.068 | 0.48 | Caspase 9 stimulant | 0.459 0.078 CID_129154 | ||
| 0.39 | 0.042 | 0.493 | 12-Lipoxygenase inhibitor | 0.493 0.022 CID_129154 | CID_129154 | |
| 0.409 | 0.071 | 0.5 | 15-Lipoxygenase inhibitor | 0.5 0.04 CID_129154 | CID_129154 | |
| 0.321 | 0.016 | 0.321 | Cholinergic | 0.266 0.025 CID_129154 | ||
| 0.302 | 0.008 | 0.302 | 5 Hydroxytryptamine agonist | 0.205 0.014 CID_129154 | ||
| 0.306 | 0.014 | 0.332 | MAO A inhibitor | 0.332 0.012 CID_129154 | CID_129154 | |
| 0.325 | 0.034 | 0.353 | 5 Hydroxytryptamine uptake stimulant | 0.353 0.025 CID_129154 | CID_129154 | |
| 0.309 | 0.019 | 0.321 | MAO inhibitor | 0.321 0.018 CID_129154 | CID_129154 | |
| 0.296 | 0.007 | 0.296 | Acetylcholine nicotinic antagonist | 0.279 0.008 CID_129154 | ||
| 0.29 | 0.005 | 0.29 | Neuronal nicotinic receptor antagonist | 0.269 0.005 CID_129154 | ||
| 0.274 | 0.004 | 0.274 | 5 Hydroxytryptamine 2 agonist | 0.184 0.004 CID_129154 | ||
| 0.289 | 0.02 | 0.289 | 5 Hydroxytryptamine antagonist | 0.15 0.05 CID_129154 | ||
| 0.383 | 0.122 | 0.409 | Apoptosis agonist | 0.409 0.109 CID_129154 | CID_129154 | |
| 0.257 | 0.004 | 0.257 | 5 Hydroxytryptamine 2A agonist | 0.205 0.004 CID_129154 | ||
| 0.228 | 0.014 | 0.228 | 5 Hydroxytryptamine 2C antagonist | 0.124 0.034 CID_129154 | ||
| 0.298 | 0.094 | 0.298 | Calcium channel activator | 0.246 0.151 CID_129154 | ||
| 0.228 | 0.024 | 0.275 | Acetylcholine antagonist | 0.275 0.016 CID_129154 | CID_129154 | |
| 0.225 | 0.026 | 0.274 | Cholinergic antagonist | 0.274 0.017 CID_129154 | CID_129154 | |
| 0.219 | 0.026 | 0.219 | 5 Hydroxytryptamine 2 antagonist | 0.128 0.054 CID_129154 | ||
| 0.205 | 0.013 | 0.205 | Acetylcholine agonist | 0.169 0.021 CID_129154 | ||
| 0.191 | 0.009 | 0.191 | Acetylcholine nicotinic agonist | 0.184 0.01 CID_129154 | ||
| 0.18 | 0.005 | 0.18 | Nicotinic receptor alpha7 subunit antagonist | 0.158 0.006 CID_129154 | ||
| 0.181 | 0.007 | 0.181 | Acetylcholine M4 receptor antagonist | 0.13 0.015 CID_129154 | ||
| 0.205 | 0.036 | 0.205 | Tubulin antagonist | 0.121 0.079 CID_129154 | ||
| 0.188 | 0.023 | 0.212 | Histone deacetylase class III inhibitor | 0.212 0.016 CID_129154 | CID_129154 | |
| 0.186 | 0.021 | 0.186 | 5 Hydroxytryptamine 2A antagonist | 0.103 0.045 CID_129154 | ||
| 0.187 | 0.029 | 0.187 | 5 Hydroxytryptamine 2B antagonist | 0.123 0.058 CID_129154 | ||
| 0.161 | 0.007 | 0.165 | Histone deacetylase SIRT2 inhibitor | 0.165 0.007 CID_129154 | CID_129154 | |
| 0.217 | 0.064 | 0.235 | Nitric-oxide synthase stimulant | 0.235 0.044 CID_129154 | CID_129154 | |
| 0.165 | 0.013 | 0.375 | Estrogen receptor beta antagonist | 0.375 0.004 CID_129154 | CID_129154 | |
| 0.173 | 0.022 | 0.173 | Alpha 2 adrenoreceptor antagonist | 0.123 0.035 CID_129154 | ||
| 0.137 | 0.003 | 0.137 | Ryanodine receptor antagonist | 0.101 0.004 CID_129154 | ||
| 0.211 | 0.078 | 0.211 | Antimitotic | |||
| 0.228 | 0.099 | 0.228 | 5 Hydroxytryptamine 1E antagonist | 0.206 0.125 CID_129154 | ||
| 0.134 | 0.005 | 0.134 | 5 Hydroxytryptamine 2C agonist | 0.117 0.006 CID_129154 | ||
| 0.15 | 0.023 | 0.311 | Estrogen antagonist | 0.311 0.005 CID_129154 | CID_129154 | |
| 0.148 | 0.023 | 0.148 | Alpha 2a adrenoreceptor antagonist | 0.115 0.031 CID_129154 | ||
| 0.14 | 0.016 | 0.219 | Dopamine D1 antagonist | 0.219 0.009 CID_129154 | CID_129154 | |
| 0.189 | 0.072 | 0.189 | P-glycoprotein inhibitor | 0.161 0.101 CID_129154 | ||
| 0.125 | 0.008 | 0.125 | Nicotinic neuronal receptor agonist | 0.094 0.014 CID_129154 | ||
| 0.129 | 0.016 | 0.329 | Estrogen receptor alpha antagonist | 0.329 0.005 CID_129154 | CID_129154 | |
| 0.15 | 0.038 | 0.15 | Alpha adrenoreceptor antagonist | 0.083 0.069 CID_129154 | ||
| 0.116 | 0.009 | 0.116 | Protease activated receptor antagonist | 0.081 0.023 CID_129154 | ||
| 0.158 | 0.051 | 0.158 | Acetylcholinesterase inhibitor | 0.119 0.079 CID_129154 | ||
| 0.125 | 0.021 | 0.125 | Factor XII inhibitor | 0.119 0.024 CID_129154 | ||
| 0.123 | 0.02 | 0.123 | 5 Hydroxytryptamine uptake inhibitor | 0.093 0.029 CID_129154 | ||
| 0.154 | 0.054 | 0.158 | MAP3K9 inhibitor | 0.158 0.049 CID_129154 | CID_129154 | |
| 0.186 | 0.087 | 0.186 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.17 0.107 CID_129154 | ||
| 0.127 | 0.028 | 0.127 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.139 | 0.041 | 0.145 | MAO B inhibitor | 0.145 0.039 CID_129154 | CID_129154 | |
| 0.154 | 0.062 | 0.229 | Amylase inhibitor | 0.229 0.034 CID_129154 | CID_129154 | |
| 0.112 | 0.022 | 0.112 | Nicotinic alpha4beta2 receptor antagonist | 0.103 0.029 CID_129154 | ||
| 0.134 | 0.045 | 0.167 | 5 Hydroxytryptamine 3A agonist | 0.167 0.027 CID_129154 | CID_129154 | |
| 0.105 | 0.017 | 0.105 | Adrenaline uptake inhibitor | 0.098 0.019 CID_129154 | ||
| 0.092 | 0.005 | 0.133 | GABA B receptor antagonist | 0.133 0.004 CID_129154 | CID_129154 | |
| 0.105 | 0.019 | 0.116 | MAP3K7 inhibitor | 0.116 0.015 CID_129154 | CID_129154 | |
| 0.212 | 0.128 | 0.27 | Lipoxygenase inhibitor | 0.27 0.087 CID_129154 | CID_129154 | |
| 0.175 | 0.099 | 0.212 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.212 0.063 CID_129154 | CID_129154 | |
| 0.101 | 0.028 | 0.132 | Cyclin B3 inhibitor | 0.132 0.018 CID_129154 | CID_129154 | |
| 0.196 | 0.122 | 0.213 | Superoxide dismutase inhibitor | 0.213 0.104 CID_129154 | CID_129154 | |
| 0.091 | 0.018 | 0.109 | Alpha 2 adrenoreceptor agonist | 0.109 0.012 CID_129154 | CID_129154 | |
| 0.082 | 0.012 | 0.082 | Nicotinic receptor alpha4 subunit antagonist | 0.081 0.013 CID_129154 | ||
| 0.117 | 0.049 | 0.117 | Butyrylcholinesterase inhibitor | 0.084 0.078 CID_129154 | ||
| 0.107 | 0.04 | 0.107 | Phosphodiesterase IV inhibitor | |||
| 0.126 | 0.061 | 0.16 | Acetylcholine muscarinic antagonist | 0.16 0.038 CID_129154 | CID_129154 | |
| 0.086 | 0.02 | 0.086 | Acetylcholine muscarinic agonist | 0.052 0.041 CID_129154 | ||
| 0.179 | 0.115 | 0.285 | Free radical scavenger | 0.285 0.056 CID_129154 | CID_129154 | |
| 0.068 | 0.006 | 0.068 | 5 Hydroxytryptamine 2B agonist | 0.047 0.016 CID_129154 | ||
| 0.094 | 0.034 | 0.094 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.086 | 0.026 | 0.099 | Acetylcholine M2 receptor antagonist | 0.099 0.021 CID_129154 | CID_129154 | |
| 0.083 | 0.024 | 0.083 | Dopamine uptake inhibitor | 0.076 0.027 CID_129154 | ||
| 0.073 | 0.018 | 0.073 | Acetylcholine M1 receptor agonist | 0.039 0.033 CID_129154 | ||
| 0.118 | 0.063 | 0.159 | Protein kinase (CK2) alpha inhibitor | 0.159 0.037 CID_129154 | CID_129154 | |
| 0.081 | 0.026 | 0.152 | Acetylcholine M3 receptor antagonist | 0.152 0.011 CID_129154 | CID_129154 | |
| 0.1 | 0.045 | 0.123 | Aminoacyl-tRNA synthetase inhibitor | 0.123 0.029 CID_129154 | CID_129154 | |
| 0.16 | 0.109 | 0.16 | I kappa B kinase epsilon inhibitor | |||
| 0.055 | 0.004 | 0.055 | Nicotinic alpha4beta2 receptor agonist | 0.05 0.005 CID_129154 | ||
| 0.158 | 0.109 | 0.17 | Psychostimulant | 0.17 0.1 CID_129154 | CID_129154 | |
| 0.051 | 0.005 | 0.051 | Nicotinic alpha3beta4 receptor agonist | 0.049 0.005 CID_129154 | ||
| 0.076 | 0.032 | 0.076 | Glutamate (mGluR7) antagonist | |||
| 0.055 | 0.012 | 0.055 | Alpha 1L adrenoreceptor agonist | 0.048 0.019 CID_129154 | ||
| 0.104 | 0.06 | 0.162 | Protein kinase (CK2) inhibitor | 0.162 0.028 CID_129154 | CID_129154 | |
| 0.124 | 0.082 | 0.124 | Toll-Like receptor 9 antagonist | |||
| 0.176 | 0.135 | 0.281 | Antioxidant | 0.281 0.069 CID_129154 | CID_129154 | |
| 0.066 | 0.026 | 0.066 | Nicotinic alpha7 receptor agonist | |||
| 0.052 | 0.016 | 0.144 | Dopamine D5 agonist | 0.144 0.003 CID_129154 | CID_129154 | |
| 0.086 | 0.054 | 0.086 | MAP-kinase-activated kinase inhibitor | 0.084 0.056 CID_129154 | ||
| 0.103 | 0.073 | 0.103 | Polo-like kinase-4 inhibitor | |||
| 0.132 | 0.102 | 0.149 | GABA C receptor rho-2 antagonist | 0.149 0.075 CID_129154 | CID_129154 | |
| 0.052 | 0.024 | 0.053 | Nicotinic receptor alpha3 subunit antagonist | 0.053 0.023 CID_129154 | CID_129154 | |
| 0.102 | 0.074 | 0.165 | GABA C receptor antagonist | 0.165 0.023 CID_129154 | CID_129154 | |
| 0.076 | 0.049 | 0.076 | MAP-kinase-activated kinase 2 inhibitor | 0.073 0.053 CID_129154 | ||
| 0.076 | 0.049 | 0.076 | Dopamine antagonist | |||
| 0.071 | 0.044 | 0.074 | Alpha adrenoreceptor agonist | 0.074 0.042 CID_129154 | CID_129154 | |
| 0.072 | 0.046 | 0.078 | Protein kinase B alpha inhibitor | 0.078 0.042 CID_129154 | CID_129154 | |
| 0.046 | 0.019 | 0.05 | Phenylethanolamine N methyltransferase inhibitor | 0.05 0.014 CID_129154 | CID_129154 | |
| 0.056 | 0.03 | 0.057 | Sigma receptor antagonist | 0.057 0.03 CID_129154 | CID_129154 | |
| 0.106 | 0.081 | 0.157 | Topoisomerase II inhibitor | 0.157 0.046 CID_129154 | CID_129154 | |
| 0.069 | 0.044 | 0.069 | Dopamine D2 antagonist | |||
| 0.044 | 0.02 | 0.051 | Retinoic acid alpha receptor agonist | 0.051 0.013 CID_129154 | CID_129154 | |
| 0.094 | 0.07 | 0.125 | GABA C receptor rho-1 antagonist | 0.125 0.036 CID_129154 | CID_129154 | |
| 0.095 | 0.073 | 0.18 | GABA C receptor agonist | 0.18 0.025 CID_129154 | CID_129154 | |
| 0.055 | 0.034 | 0.055 | Nicotinic alpha3beta2 receptor antagonist | 0.054 0.036 CID_129154 | ||
| 0.051 | 0.031 | 0.051 | Dopamine transporter inhibitor | 0.047 0.035 CID_129154 | ||
| 0.025 | 0.007 | 0.025 | Progesterone receptor B antagonist | 0.025 0.007 CID_129154 | ||
| 0.139 | 0.122 | 0.139 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.023 | 0.006 | 0.023 | Nicotinic alpha4 receptor agonist | 0.018 0.009 CID_129154 | ||
| 0.06 | 0.045 | 0.06 | Dopamine D3 antagonist | |||
| 0.098 | 0.086 | 0.17 | Adenylate cyclase inhibitor | 0.17 0.034 CID_129154 | CID_129154 | |
| 0.196 | 0.186 | 0.196 | Vasodilator, coronary | |||
| 0.022 | 0.012 | 0.022 | Imidazoline I1 receptor antagonist | |||
| 0.194 | 0.184 | 0.199 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.199 0.169 CID_129154 | CID_129154 | |
| 0.062 | 0.053 | 0.062 | Acetylcholine M5 receptor agonist | |||
| 0.078 | 0.07 | 0.078 | Insulin growth factor antagonist | |||
| 0.129 | 0.121 | 0.155 | Nitric oxide antagonist | 0.155 0.09 CID_129154 | CID_129154 | |
| 0.075 | 0.068 | 0.075 | Insulin like growth factor 1 antagonist | |||
| 0.075 | 0.068 | 0.075 | Calcium antagonist | |||
| 0.16 | 0.155 | 0.16 | ErbB-1 antagonist | |||
| 0.052 | 0.048 | 0.052 | 5 Hydroxytryptamine 7 agonist | |||
| 0.012 | 0.009 | 0.012 | Melatonin 2 antagonist | |||
| 0.024 | 0.022 | 0.024 | Acid ceramidase inhibitor | |||
| 0.031 | 0.029 | 0.055 | Protein kinase (CK2) beta inhibitor | 0.055 0.005 CID_129154 | CID_129154 | |
| 0.066 | 0.065 | 0.067 | CYP2A6 inhibitor | 0.067 0.064 CID_129154 | CID_129154 | |
| 0.053 | 0.053 | 0.066 | Cyclin B1 inhibitor | 0.066 0.036 CID_129154 | CID_129154 | |
| 0.047 | 0.049 | 0.049 | GABA receptor antagonist | 0.049 0.045 CID_129154 | CID_129154 | |
| 0.1 | 0.104 | 0.14 | Toll-Like receptor 2 antagonist | 0.14 0.06 CID_129154 | CID_129154 | |
| 0.012 | 0.018 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.012 CID_129154 | CID_129154 | |
| 0.159 | 0.167 | 0.211 | MAP-kinase-activated kinase 5 inhibitor | 0.211 0.09 CID_129154 | CID_129154 | |
| 0.136 | 0.144 | 0.17 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.17 0.114 CID_129154 | CID_129154 | |
| 0.097 | 0.105 | 0.139 | Interleukin 8 antagonist | 0.139 0.042 CID_129154 | CID_129154 | |
| 0.08 | 0.088 | 0.104 | Protein kinase C zeta inhibitor | 0.104 0.046 CID_129154 | CID_129154 | |
| 0.046 | 0.055 | 0.057 | Cyclin B2 inhibitor | 0.057 0.036 CID_129154 | CID_129154 | |
| 0.062 | 0.072 | 0.098 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.098 0.039 CID_129154 | CID_129154 | |
| 0.176 | 0.186 | 0.254 | Tyrosine 3 hydroxylase inhibitor | 0.254 0.064 CID_129154 | CID_129154 | |
| 0.058 | 0.069 | 0.071 | Telomerase inhibitor | 0.071 0.051 CID_129154 | CID_129154 | |
| 0.102 | 0.114 | 0.178 | Lipid peroxidase inhibitor | 0.178 0.051 CID_129154 | CID_129154 | |
| 0.118 | 0.136 | 0.161 | Amyloid beta aggregation inhibitor | 0.161 0.1 CID_129154 | CID_129154 | |
| 0.116 | 0.135 | 0.158 | Adenylate cyclase stimulant | 0.158 0.05 CID_129154 | CID_129154 | |
| 0.119 | 0.137 | 0.14 | Melanin inhibitor | 0.14 0.097 CID_129154 | CID_129154 | |
| 0.042 | 0.062 | 0.052 | CD45 antagonist | 0.052 0.031 CID_129154 | CID_129154 | |
| 0.042 | 0.063 | 0.052 | Cyclin B inhibitor | 0.052 0.043 CID_129154 | CID_129154 | |
| 0.014 | 0.037 | 0.135 | Estrogen receptor beta agonist | 0.135 0.008 CID_129154 | CID_129154 | |
| 0.131 | 0.158 | 0.157 | Dyrk kinase inhibitor | 0.157 0.129 CID_129154 | CID_129154 | |
| 0.051 | 0.083 | 0.085 | Na+ K+ transporting ATPase inhibitor | 0.085 0.046 CID_129154 | CID_129154 | |
| 0.154 | 0.188 | 0.2 | RNA-directed DNA polymerase inhibitor | 0.2 0.1 CID_129154 | CID_129154 | |
| 0.119 | 0.153 | 0.149 | Hepatoprotectant | 0.149 0.111 CID_129154 | CID_129154 | |
| 0.014 | 0.048 | 0.023 | Dopamine D1 agonist | 0.023 0.016 CID_129154 | CID_129154 | |
| 0.044 | 0.083 | 0.067 | Sphingosine kinase inhibitor | 0.067 0.028 CID_129154 | CID_129154 | |
| 0.036 | 0.075 | 0.054 | Topoisomerase II beta inhibitor | 0.054 0.028 CID_129154 | CID_129154 | |
| 0.095 | 0.134 | 0.116 | Protein kinase stimulant | 0.116 0.097 CID_129154 | CID_129154 | |
| 0.029 | 0.069 | 0.042 | Mannosidase inhibitor | 0.042 0.036 CID_129154 | CID_129154 | |
| 0.136 | 0.178 | 0.17 | Spasmolytic | 0.17 0.145 CID_129154 | CID_129154 | |
| 0.021 | 0.073 | 0.094 | Estrogen agonist | 0.094 0.019 CID_129154 | CID_129154 | |
| 0.027 | 0.08 | 0.039 | Sphingosine kinase 1 inhibitor | 0.039 0.033 CID_129154 | CID_129154 | |
| 0.06 | 0.114 | 0.071 | GABA B receptor agonist | 0.071 0.065 CID_129154 | CID_129154 | |
| 0.095 | 0.15 | 0.126 | Acetylcholine M1 receptor antagonist | 0.126 0.1 CID_129154 | CID_129154 | |
| 0.021 | 0.079 | 0.04 | Estrogen-related receptor beta antagonist | 0.04 0.011 CID_129154 | CID_129154 | |
| 0.073 | 0.133 | 0.1 | Beta glucuronidase inhibitor | 0.1 0.07 CID_129154 | CID_129154 | |
| 0.044 | 0.115 | 0.07 | Topoisomerase II alpha inhibitor | 0.07 0.061 CID_129154 | CID_129154 | |
| 0.057 | 0.13 | 0.082 | HIV-1 integrase (Overall Integration) inhibitor | 0.082 0.074 CID_129154 | CID_129154 | |
| 0.064 | 0.139 | 0.08 | D-Ala-D-Ala ligase inhibitor | 0.08 0.07 CID_129154 | CID_129154 | |
| 0.18 | 0.255 | 0.292 | Antibacterial | 0.292 0.141 CID_129154 | CID_129154 | |
| 0.047 | 0.125 | 0.087 | Androgen antagonist | 0.087 0.057 CID_129154 | CID_129154 | |
| 0.163 | 0.244 | 0.213 | Apoptosis antagonist | 0.213 0.164 CID_129154 | CID_129154 | |
| 0.047 | 0.134 | 0.103 | Monophenol monooxygenase inhibitor | 0.103 0.073 CID_129154 | CID_129154 | |
| 0.061 | 0.149 | 0.103 | Cystathionine beta-synthase inhibitor | 0.103 0.073 CID_129154 | CID_129154 | |
| 0.09 | 0.18 | 0.125 | Arachidonic acid antagonist | 0.125 0.12 CID_129154 | CID_129154 | |
| 0.052 | 0.154 | 0.092 | Prolactin inhibitor | 0.092 0.064 CID_129154 | CID_129154 | |
| 0.056 | 0.161 | 0.085 | MAP kinase kinase 7 inhibitor | 0.085 0.034 CID_129154 | CID_129154 | |
| 0.114 | 0.235 | 0.129 | Ca2+-transporting ATPase inhibitor | 0.129 0.127 CID_129154 | CID_129154 | |
| 0.152 | 0.285 | 0.294 | GABA C receptor rho-3 antagonist | 0.294 0.12 CID_129154 | CID_129154 | |
| 0.144 | 0.28 | 0.243 | Sodium/bile acid cotransporter inhibitor | 0.243 0.136 CID_129154 | CID_129154 | |
| 0.103 | 0.243 | 0.152 | Phospholipase C inhibitor | 0.152 0.103 CID_129154 | CID_129154 | |
| 0.028 | 0.176 | 0.051 | Fatty acid synthase inhibitor | 0.051 0.05 CID_129154 | CID_129154 | |
| 0.058 | 0.23 | 0.103 | DOPA decarboxylase inhibitor | 0.103 0.069 CID_129154 | CID_129154 | |
| 0.165 | 0.347 | 0.309 | Calcium channel L-type activator | 0.309 0.15 CID_129154 | CID_129154 | |
| 0.03 | 0.301 | 0.104 | Creatine kinase inhibitor | 0.104 0.055 CID_129154 | CID_129154 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |